Search

Your search keyword '"Mark A. Rubin"' showing total 1,188 results

Search Constraints

Start Over You searched for: Author "Mark A. Rubin" Remove constraint Author: "Mark A. Rubin"
1,188 results on '"Mark A. Rubin"'

Search Results

1. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

2. Alterations in homologous recombination repair genes in prostate cancer brain metastases

3. Comparative pathology of dog and human prostate cancer

4. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

5. G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer

6. Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia

7. Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

8. Patient-derived xenografts and organoids model therapy response in prostate cancer

9. Common germline-somatic variant interactions in advanced urothelial cancer

10. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

11. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma

12. Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

13. Pathway and network analysis of more than 2500 whole cancer genomes

14. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

15. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes

16. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

17. NSD2 is a conserved driver of metastatic prostate cancer progression

18. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

19. Patient derived organoids to model rare prostate cancer phenotypes

20. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

21. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network

22. Inherited determinants of early recurrent somatic mutations in prostate cancer

23. A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors

24. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

25. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

26. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

27. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

28. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

29. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

30. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

31. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

32. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

33. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

34. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

35. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

36. The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

37. SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts

38. Identification of Molecular Tumor Markers in Renal Cell Carcinomas with TFE3 Protein Expression by RNA Sequencing

39. Epigenomic Alterations in Localized and Advanced Prostate Cancer

40. Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer

41. ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression

42. Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

43. RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease

44. N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer

45. Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer

46. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

47. Molecular Characterization of TMPRSS2-ERG Gene Fusion in the NCI-H660 Prostate Cancer Cell Line: A New Perspective for an Old Model

48. Genomic Profiling of Hormone-Naïve Lymph Node Metastases in Patients with Prostate Cancer

49. Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer

50. ADAM15 Disintegrin Is Associated with Aggressive Prostate and Breast Cancer Disease

Catalog

Books, media, physical & digital resources